Most immune-related target genes of the canonical NF-κB pathway were down-regulated in tumour-induced DCs, including cytokines, chemokines, immunoreceptors, and several transcription factors, indicating that the canonical NF-κB pathway was attenuated in the cancer group. The gene discussed is NFKB1; the disease is cancer.